EP4553149A3
(en )
2025-07-23
Liver organoid, uses thereof and culture method for obtaining them
CA2726756C
(en )
2021-06-01
Energy consumption reporting and modification system
EP3441468A3
(en )
2019-04-03
Delivery methods and compositions for nuclease-mediated genome engineering
EP2935849A4
(en )
2016-11-02
MEDIUM CYCLE FUEL INJECTION STRATEGIES
NZ701125A
(en )
2016-11-25
Improved chymosine enzyme variants
DK2077877T3
(da )
2020-03-16
Nålefri indsprøjtningsindretning, som kan lades automatisk
MY192032A
(en )
2022-07-24
Pharmaceutical composition with improved bioavailability
MX358095B
(es )
2018-08-06
Medios de cultivo celular.
EP4470544A3
(en )
2025-06-18
Methods and compositions for reprogramming cells
MX340248B
(es )
2016-07-01
Celobiohidrolasa mutante.
IN2014CN02455A
(th )
2015-08-07
WO2013036910A3
(en )
2013-05-02
Rotating attachment device and method of use
NZ628904A
(en )
2016-08-26
Injection moulded article
BR112012017532A2
(pt )
2019-09-24
"método para determinar um polipeptídeo com uma sequência de aminoácidos mutante, para produzir um poliptedo e uma imunoglobulina"
BR112014000542A2
(pt )
2017-02-14
composições de peroxidase eosinofílica e métodos de uso das mesmas
WO2012091906A3
(en )
2012-09-13
Process for reducing one or more insoluble solids in a black liquor
MX2018010801A
(es )
2019-02-07
Derivados de acido a-truxilico y composiciones farmaceuticas de los mismos.
WO2013029011A8
(en )
2014-04-17
Methods and compositions comprising a c-terminal bax peptide
UA115072C2
(uk )
2017-09-11
Похідні гідантоїну
PT2620153T
(pt )
2018-07-18
Injecção de 5α-androstano-3β,5,6β-triol e método de preparação desta
UA103290C2
(ru )
2013-09-25
Фармацевтическая композиция ибупрофена для инъекции
MY184391A
(en )
2021-04-01
Microorganism having improved intracellular energy level and method for producing l-amino acid using same
EA033071B1
(ru )
2019-08-30
Способ увеличения выхода продуктов из ацетолактата
IN2014DN09242A
(th )
2015-07-10
MX2014013255A
(es )
2015-01-16
Endoglucanasas con propiedades mejoradas.